Medivir partners with world-leading liver cancer experts in

/PRNewswire/ -- Medivir AB (Nasdaq: MVIR) (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high...

Related Keywords

Glasgow , Glasgow City , United Kingdom , Barcelona , Comunidad Autonoma De Cataluna , Spain , Hannover , Niedersachsen , Germany , Stockholm , Sweden , Scotland , Jeff Evans , Richard Finn , Jeong Heo , Magnus Christensen , Pia Baumann , Maria Reig , Arndt Vogel , School Of Cancer Sciences , Glasgow Experimental Cancer Medicine Centre , Professor Of Translational Cancer Research , Scotland Cancer Centre , National Clinical , Scotland Cancer Research Network , Hannover Medical School , Department Of Medicine , Medivir Scientific Advisory Council , Department Of Gastroenterology , Division Of Hematology Oncology , Translational Research Laboratory , University Of Glasgow , Guidelines Steering Committee , Hepatobiliary Cancer Study Group , Geffen School Of Medicine , Personalized Medicine At Medical School Hannover , Scientific Advisory Council , Pusan National University Hospital , Scientific Advisory , Geffen School , Translational Cancer Research , Cancer Sciences , Honorary Consultant , Medical Oncology , Beatson West , National Clinical Lead , Cancer Research , Internal Medicine , Pusan National University School , Pusan National University , Professor Heo , Liver Oncology , Hospital Clinic , Hannover Medical , Cancer Center , Personalized Medicine , Medical School , Professor Vogel , Nasdaq Stockholm , Small Cap , Medivir ,